secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001493152-24-028770
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition terminates merger with Visiox Pharmaceuticals on July 19
----------------------------------------------------------------------------

- Terminated Merger Agreement with Visiox Pharmaceuticals due to failure to satisfy closing conditions by June 30, 2024.
- Company intends to continue evaluating other business combination targets but provides no assurance.
- Termination effective July 19, 2024; no transaction resulted.
- No financial terms of the abandoned merger were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/0001493152-24-028770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-028770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer